The mycobacterial cell envelope is unique in its chemical composition, and has an important role to play in pathogenesis. Phthiocerol dimycocerosates (PDIMs) and glycosylated phenolphthiocerol dimycocerosates, also known as phenolic glycolipids (PGLs), contribute significantly to the virulence of Mycobacterium tuberculosis. FadD22 is essential for PGL biosynthesis. We have recently shown in vitro that FadD22 is a substrate for lysine acylation by a unique cAMP-dependent, protein lysine acyltransferase found only in mycobacteria. The lysine residue that is acylated is at the active site of FadD22. Therefore, acylation is likely to inhibit FadD22 activity and reduce PGL biosynthesis. Here, we show accumulation of PGLs in a strain of M. bovis BCG deleted for the gene encoding the cAMP-dependent acyltransferase, kat bcg , with no change seen in PDIM synthesis. Complementation using KAT bcg mutants that are deficient in cAMP-binding or acyltransferase activity shows that PGL accumulation is regulated by cAMP-dependent protein acylation in vivo. Expression of FadD22 and KAT bcg mutants in Mycobacterium smegmatis confirmed that FadD22 is a substrate for lysine acylation by KAT bcg . We have therefore described a mechanism by which cAMP can regulate mycobacterial virulence as a result of the ability of this second messenger to modulate critical cell wall components that affect the host immune response.
INTRODUCTION
Tuberculosis is estimated to have affected one third of the world's population and causes millions of death annually [1] . The increased incidence of multidrug-resistant (MDR) and the emergence of extremely drug-resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) make the disease a major global threat to health care in the 21st century [2] [3] [4] [5] .
A large number of studies have highlighted the key role of the mycobacterial cell envelope in virulence. Among the surface-exposed and non-covalently linked lipids, phthiocerol dimycocerosates (PDIMs) and glycosylated phenolphthiocerol dimycocerosates, also known as phenolic glycolipids (PGLs), contribute significantly to mycobacterial virulence [6] [7] [8] [9] [10] [11] . PDIMs and PGLs are diesters of long-chain methylbranched fatty acids and aliphatic polyketides (Fig. 1) . With the exception of Mycobacterium gastri, PDIMs occur only in the pathogenic strains of mycobacteria, such as Mycobacterium tuberculosis, M. leprae, M. bovis, M. marinum, M. africanum, M. ulcerans and M. kansasii [8] . PGLs are also produced by these bacteria, but can be absent from some strains of M. tuberculosis [12] . The biosynthetic pathway for PGLs is well established in mycobacteria [13] (Fig. 1) . Upon activation of p-hydroxybenzoic acid (p-HBA) by FadD22, the adenylated derivative is used as a starter unit by polyketide synthase Pks15/1, and subsequently by PpsA-E, to elongate the chain leading to the formation of phenolphthiocerol [14] [15] [16] . This lipid in turn is esterified and glycosylated, resulting in the formation of PGLs. This is suggested to be the sole pathway for biosynthesis of PGLs in M. tuberculosis [13] .
The contribution of PGLs to the virulence of M. tuberculosis remains controversial. For example, laboratory strains of Mtb (H37Rv and Erdman) and many clinical isolates (CDC1551 and MT103) do not produce PGLs, due to a mutation in the polyketide synthase gene (Pks15/1; Fig. 1 ), while some clinical isolates of East Asian lineage produce PGLs due to the presence of an intact pks15/1 gene [17] . Thus, W-Beijing strains of M. tuberculosis that harbour an intact pks15/1 gene are capable of producing PGLs, which could account for the hypervirulence of such strains [17] . A PGL-deficient M. bovis mutant was attenuated for virulence in a guinea pig model of infection [18] , and overproduction of PGLs led to an inhibition of pro-inflammatory cytokine release and increase in anti-inflammatory cytokine release by macrophages, suggesting that PGLs confer an immunesuppressive effect on host macrophages [17, 19, 20] .
There is a plethora of proteins involved in cAMP metabolism in mycobacteria [21] , and utilization of cAMP as a signalling molecule for regulating gene expression in both virulent and avirulent mycobacteria has been described [22] [23] [24] . A unique downstream target of cAMP in mycobacteria is a cAMP-binding, protein lysine acyltransferase, which we have previously characterized and call KAT (for lysine acyltransferase) [25] . KAT mt is the product of the gene Rv0998 from M. tuberculosis, and cAMP binding to this protein is obligatory for its acyltransferase activity. Substrates for lysine acylation by KAT mt or its orthologue in M. smegmatis (KAT ms ; [26] ) include enzymes that are important for central carbon metabolism in mycobacteria [27, 28] . Moreover, we have shown by in vitro studies using purified proteins, that KAT mt can acylate a number of fatty acyl CoA ligases (FadDs) [29] . Acylation occurs on a lysine residue in the active site of these FadD enzymes, which inhibits the fatty acyl CoA ligase activity. Interestingly, FadD22 (Rv2948c) was also acylated by KAT mt on the active site lysine residue [14] , suggesting that acylation of this enzyme may serve as a means of modulating PGL biosynthesis. Here, we show that synthesis of PGLs is regulated in vivo by cAMP-dependent acylation of FadD22, thus providing evidence of a new role for cAMP in modulating the virulence of pathogenic mycobacteria. included. Cultures were maintained under static conditions. Hygromycin B, kanamycin or gentamicin as required, was added to the culture medium at a concentration of 50, 10 and 5 µg ml
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À1
, respectively. Strains used in this study are shown in Table 1 .
Cloning and expression of fadD22 and kat bcg For plasmid-borne overexpression of fadD22 under the sigA promoter, the KpnI-BamHI fragment from pBKS-sigA and BamHI-HindIII fragment from pPRO_FadD22 [29] were cloned into the KpnI-HindIII-digested pMV10-25 plasmid to generate pMV10-25_FadD22, which would impart hygromycin B resistance. A similar cloning strategy was undertaken to generate pNS261_FadD22 (pNS261 imparts gentamicin resistance and was a kind gift from Dr Roger Buxton, National Institute of Medical Research, London).
KAT mt is identical to the KAT expressed in M. bovis BCG. Since we performed experiments in the current study utilizing the M. bovis BCG strain, we refer to the lysine acyltransferase as KAT bcg hereafter. The NotI-EcoRI fragment from pBKS_Oprom-KAT bcg [26] was cloned into the similarly digested pMV306 plasmid to generate pMV306_Oprom-KAT bcg . This plasmid was transformed into M. smegmatis and allowed expression of wild-type KAT bcg driven by a promoter present in the upstream region of the kat bcg gene [26] . In order to express a mutant of KAT bcg that does not bind cAMP, the XbaI-BglII fragment from pBKS_Oprom-KAT bcg and BglII-XhoI fragment from pPRO_KAT bcg R98K [26] were cloned into XbaI-SalI-digested pMV306, to generate pMV306_Oprom-KAT bcg R98K . A similar strategy was followed to generate pMV306_Oprom-KAT bcg
E235A
, a catalytically inactive mutant of KAT bcg [26] .
The generation of the Dkat ms and Dkat bcg strains has been described previously [25, 29] . Plasmids pMV306_Oprom-KAT bcg , pMV306_Oprom-KAT bcg R98K or pMV306_Oprom-KAT bcg E235A were electroporated independently into either the Dkat ms or Dkat bcg strain. Cultures were harvested at the log phase of growth, and expression of kat bcg or fadD22 RNA was monitored by reverse transcription and PCR (RT-PCR) as described previously [29] . Primers used are shown in Table 2 .
TLC analysis of lipids [1, 2 -14 C] sodium acetate (specific activity~31.70 mCi mmol
À1
; BRIT, India) was added to cultures (10 ml) in the exponential phase of growth (OD 600 of~1), at a concentration of 1 µCi ml
, followed by incubation for 3 days for M. smegmatis (shaking cultures) and 7 days for M. bovis BCG (static culture). After harvesting the cells by centrifugation, cell pellets were dried at 65 C in glass tubes. To the dried biomass, 2 ml of methanol/0.3 % NaCl (10 : 1, v/v) was added, vortexed and sonicated at 25 C for 40 min. Two millilitres of petroleum ether was added, tubes vortexed and mixed on a rotator for 20 min. The suspension was centrifuged at 3000 r.p.m. for 5 min, and the upper layer collected. The extraction was repeated, and the petroleum ether fractions pooled. The tubes were dried at 65 C, and the dried residue represented the non-polar lipids. This residue was resuspended in 200 µl chloroform/methanol (2 : 1, v/v), and equal radioactivity (~25 000 d.p.m.) from each sample was analysed by twodimensional thin-layer chromatography (2D-TLC). Samples Table 1 . Bacterial strains used in this study Episomal expression of fadD22 was driven by the sigA promoter. kat bcg and kat ms were driven by their endogenous promoters in integrative plasmids pMV306 and pMH94h, respectively. Fig. 2 . Protein acylation regulates the production of PGLs in M. bovis BCG. (a) RT-PCR analysis of kat bcg and mutants as indicated in wild-type M. bovis BCG and Dkat bcg strains. 16s was used to normalize cDNA synthesis. RNA was also subjected to direct PCR without cDNA synthesis to ensure the amplicon that was detected did not originate from genomic DNA. (b) 2D-TLC analysis designed to visualize PGLs was performed with [1, 2 - 14 C] sodium acetate-labelled apolar lipids, prepared from the indicated strains, expressing either wild-type, a cAMP-binding-deficient (R98K) or acyltransferase-inactive (E235A) form of KAT bcg . Arrows at the bottom left corner of the chromatograms indicate the directions of the first (1) and second (2) dimension runs. Arrows within the chromatograms indicate the spots representing PGLs. The panel on the right shows pixel density using Image J; values represent data from two independently labelled cultures, and the line is the mean. Indicated on the x-axis are the proteins expressed in the Dkat bcg strain, or strains alone (À). (c) Unlabelled lipid migrating at a position corresponding to the spot seen in the TLC was eluted from the TLC plate and analysed by mass spectrometry. Spectra shown indicate a major lipid species of mass~1531 representing the PGL. Arrows show peaks separated by~14 Da, representing lipids altered in the addition or removal of a -CH 2 group in the lipid chain. (d) 14 C-labelled apolar lipids were prepared from the indicated strains, and PDIMs resolved by 2D-TLC using petroleum ether/ethyl acetate (98 : 2, by vol) in the first dimension, and petroleum ether/acetone (98 : 2, by vol) in the second dimension. Arrows represent the migration positions of PDIMs were applied to silica gel 60 F 254 plates (Merck), and resolved using chloroform/methanol (95 : 5, v/v) in the first dimension, and toluene/acetone (70 : 30, v/v) in the second dimension [30] to resolve PGLs. Radioactivity was monitored using a phospho-imager (Bass 1800; Fuji). The intensity of spots moving at equivalent positions was monitored by densitometric analysis using Image J, and experiments were repeated twice.
Polar and apolar lipids were prepared from strains of M. smegmatis. Following isolation of apolar lipids, equal radioactivity (~25 000 d.p.m.) was spotted on TLC plates and resolved using chloroform/methanol (96 : 4, v/v) in the first dimension, and toluene/acetone (80 : 20, v/v) in the second dimension. To identify trehalose dimycolates (TDMs) in the apolar fraction, lipids were resolved by chloroform/ methanol/water (100 : 14 : 0.8, by vol.) in the first dimension, and chloroform/acetone/methanol/water (50 : 60 : 2.5 : 3, by vol.) in the second dimension. To extract the polar lipid fraction, the cell residue was treated with 2.3 ml chloroform/ methanol/0.3 % NaCl (9 : 10 : 3, by vol.) and mixed on a rotator for 60 min. The sample was centrifuged for 5 min at 3000 r.p.m. and the supernatant collected. The cell pellet was again treated with 750 µl chloroform/methanol/0.3 % NaCl (5 : 10 : 4, by vol.), mixed on a rotator for 30 min, centrifuged for 3 min at 3000 r.p.m., and supernatants pooled with the supernatant from the first extraction. This was repeated once more, and 1.3 ml chloroform and 1.3 ml 0.3 % NaCl were added to the pooled extracts, allowing two phases to form. After mixing for 5 min, the sample was centrifuged for 5 min at 3000 r.p.m., and the lower layer containing polar lipids was collected using a long Pasteur pipette, transferred to a separate tube and dried at 65 C. The polar lipids were resuspended in 200 µl chloroform/methanol (2 : 1, v/v) and subjected to 2D-TLC in chloroform/methanol/water (60 : 30 : 6, by vol.) in the first dimension and chloroformchloroform/acetic acid/methanol/water (40 : 25 : 3 : 6, by vol.) in the second dimension (System E) [30] . Data shown are representative of experiments repeated twice. Extracted samples were centrifuged to remove silica and further filtered through glass wool to remove residual silica. The extracts were dried and were re-dissolved in chloroform/methanol (3 : 1, v/v) prior to mass spectrometry.
Mass spectrometric analysis of lipids
Samples were delivered directly to the Alliance e2695 HPLC system linked to the Synapt G25-TOF-MS Unit (Waters). Mass spectra were obtained in negative electrospray resolution mode with the following parameters: capillary voltage 2kV, sample cone 40V, source temperature 130 C, desolvation temperature 250 C, cone gas flow 60 l h
À1
, desolvation gas flow 500 l h À1 . The data was processed using MassLynx V4.1 SCN 924 (Waters).
RESULTS
Acylation-mediated regulation of PGL synthesis in mycobacteria FadD22 activates p-HBA to prime PGL biosynthesis (Fig. 1) . We therefore hypothesized that KAT bcg -mediated acylation of FadD22 on its active site lysine residue (Lysine 479; [29] ) would inhibit FadD22 activity, thereby reducing levels of the first intermediate required for PGL production and preventing further steps in the biosynthesis of PGLs. To test this, we compared the levels of 14 C-labelled PGLs in M. bovis BCG (wild-type) and a strain deleted for kat bcg (Dkat bcg ; Fig. 2a, b) . Indeed, radioactivity in a spot corresponding to PGLs was more intense in lipids prepared from the Dkat bcg strain than from the wild-type strain (Fig. 2b) . The intensity of the PGL spot was reduced in a Dkat bcg strain that was complemented with wild-type KAT bcg (Fig. 2b) . Following 2D-TLC, we isolated the lipids present in the region of the spot and performed mass spectrometry (Fig. 2c) . The ES-MS spectrum showed a peak with m/z 1531 representing the PGL, and other mass units at 14 Da intervals as molecule-related ions, representing acyl chains differing in the length of the methylene group [31] .
The enhanced intensity of the radiolabelled spot could represent increased overall abundance of PGLs in the Dkat bcg strain and/or an increase in the incorporation of 14 C-acetate specifically into PGLs. We did not detect a significant change in the uptake of radioactive acetate, as measured by the amount of radioactivity present in cell pellets prepared from different strains. We therefore propose that the incorporation of radioactive acetate was higher in PGLs in the Dkat bcg strain, which would harbour non-acylated, and therefore active, FadD22.
FadD22 is not involved in the biosynthesis of PDIMs (Fig. 1) , and its deletion does not alter PDIM levels in M. marinum or M. tuberculosis [11, 15, 32] . Acylation of FadD22 (resulting in its inactivation) would mimic a strain deleted for fadD22. Therefore, we monitored PDIM levels in the Dkat bcg strain to confirm that FadD22 acylation specifically modulated the production of only PGLs. As shown in Fig. 2(d) , PDIM levels remained unchanged in the wildtype, Dkat bcg and complemented strains. Interestingly, FadD26, which is required for PDIM production [7, 15] (Fig. 1) , was not acylated by KAT bcg [29] , and therefore we predicted it would remain as active in the Dkat bcg strain as in the wild-type strain. [30] . TAG is triacylglycerol, whose levels are reduced in the deletion strain but not restored on complementation with wild-type KAT bcg .
The panel on the right shows pixel density using Image J; values represent data from two independently labelled cultures, and the line is the mean. C] acetate-labelled apolar lipids were isolated and resolved by 2D-TLC. The top panels were resolved in chloroform/methanol (96 : 4, by vol) in the first dimension, and toluene/acetone (80 : 20, by vol) in the second dimension. The lower panels were resolved using chloroform/methanol/water (100 : 14 : 0.8, by vol) in the first dimension, and chloroform/ acetone/methanol/water (50:60 : 2.5 : 3, by vol) in the second dimension. Arrows at the corner of the chromatogram indicate the directions of the first (1) and second (2) dimension runs. Lipids are identified based on earlier reports [49] . No significant differences in apolar lipids were observed in the Dkat ms strains harbouring either the vector alone or a plasmid encoding fadD22. (c) 2D-TLC analysis performed with the [1, 2 - 14 C] acetate-labelled polar lipids from the indicated strains. Arrows at the corner of the chromatogram indicate the directions of the first (1) and second (2) dimension runs in System E [30] . Filled arrows within the chromatograms indicate the position of characterized lipids [30, 50] . Broken circle identifies spots corresponding to higher phosphatidylinnositol mannosides (PIMs). A spot that showed a greater intensity in the Dkat ms strain expressing FadD22 is shown by an open arrow. The intensity of this spot was reduced on complementation of the Dkat ms strain with a copy of the kat ms gene. The graph on the right shows the pixel density using Image J; values represent data from two independently labelled cultures, and the line is the mean. Indicated on the x-axis are the proteins expressed in the Dkat ms strain, or strains alone (-).
IP
A spot close to the origin in the wild-type strain, representing triacylglycerol (TAG), was reduced in the knock-out strain (Fig. 2d) . However, the level of TAG was not restored in the complemented strain, suggesting this effect was not related to gene deletion, so we did not study this change further.
We also monitored the changes in other polar and apolar lipids in the Dkat bcg strain using two additional solvent systems [30] , and reproducibly found no significant differences in any other lipid (Fig. S1 , available in the online Supplementary Material).
To confirm that the increase in PGL levels in the Dkat bcg strain was due to acylation of FadD22 by KAT bcg , we expressed a mutant of KAT bcg (E235A) that we had earlier shown to be inactive in terms of acyltransferase activity [26] . As shown in Fig. 2(b) , levels of PGLs remained elevated in the Dkat bcg strain expressing the E235A mutant of KAT bcg . These results strongly suggest that the acyltransferase activity of KAT bcg can modulate PGL synthesis, presumably by acylation of FadD22.
Synthesis of PGLs is dependent on cAMP binding to KAT bcg KAT bcg is an active acyltransferase only in the presence of cAMP, since a dramatic conformational change occurs following cAMP binding that allows access of substrates to the acyltransferase domain [33] . We investigated whether binding of intracellular cAMP to KAT bcg regulates PGL synthesis. We complemented the Dkat bcg strain with a mutant protein (KAT bcg R98K ), which lacks the arginine residue essential for cAMP binding [26] . The Dkat bcg strain expressing KAT bcg R98K (Fig. 2a) continued to show an increase in PGLs (Fig. 2b) . Therefore, levels of intracellular cAMP could indeed determine the extent of FadD22 acylation in the cell, and thereby production of PGLs.
KAT-mediated acylation of heterologously expressed FadD22 alters host strain polar lipid profiles M. smegmatis neither harbours an orthologue of FadD22, nor the genetic repertoire to produce PGLs. KAT ms is a close orthologue of KAT bcg , sharing 57 % sequence identity and 73 % similarity [25] . Both enzymes can acylate common substrates, such as the universal stress protein, MSMEG_4207 [25] . Therefore, it is likely that FadD22 could be acylated in vivo by KAT ms . We thus used M. smegmatis to monitor acylation-mediated regulation of FadD22, exclusively by KAT bcg . FadD22 expression in M. smegmatis (Fig. 3a) did not alter apolar lipid profiles in Dkat ms M. smegmatis strains (Fig. 3b) . However, overproduction of a polar lipid species was observed in the Dkat ms strain (Fig. 3c) on expression of FadD22. This labelled lipid spot was absent following complementation with wild-type KAT ms in the Dkat ms strain (Fig. 3c) . We were unable to ascertain the identity of this lipid by mass spectrometry (data not shown). Nevertheless, the presence of this distinct lipid provided us with an opportunity to study direct regulation of FadD22 activity by acylation via KAT bcg .
Utilizing the FadD22-expressing Dkat ms strain, we expressed wild-type and mutant constructs of KAT bcg (Fig. 4a) . While complementation with a functional copy of kat bcg did not result in the production of the polar lipid, complementation with KAT bcg R98K , or KAT bcg E235A continued to show the presence of the polar lipid (Fig. 4b) .
In summary, the results described here demonstrate that the in vivo activity of FadD22 is regulated by KAT bcg -mediated acylation of FadD22, that in turn was regulated by intracellular cAMP.
DISCUSSION
PGLs produced by the majority of the pathogenic mycobacterial strains are surface-exposed bioactive glycolipids, and function as small-molecule effectors of mycobacterial virulence. The present report provides an insight into the molecular mechanism of acylation-mediated regulation of PGL biosynthesis in mycobacteria. We propose the following model, depicted in Fig. 5 . Activation of adenylyl cyclases in the bacterium elevates cAMP, which will now bind to KAT bcg , resulting in acylation of FadD22. This acylation will now reduce the activity of FadD22, thereby preventing the formation of the starter unit required to initiate PGL biosynthesis. Therefore, cAMP can modulate the virulence of mycobacteria not just by secretion of the second messenger into the macrophage, but also by modulating the levels of virulence factors such as PGLs in the invading bacterium. For example, it has been shown that cAMP levels in mycobacteria increase rapidly during macrophage uptake [34] , and this could be a mechanism by which the pathogen can decrease PGL biosynthesis in order to divert lipid utilization towards survival in the macrophage. This could also be a reason why the deletion of pks15/1 is seen in some virulent strains of M. tuberculosis.
As a reversible and dynamic process, protein acylation has important roles in many organisms across multiple cellular processes [35] [36] [37] [38] . Proteome-wide acylation studies in M. tuberculosis identified a number of proteins that are acylated, and include those involved in protein synthesis and central carbon metabolism [36, 39] . Genetic analysis has indicated that the activity of acyl CoA synthase is modulated by acylation via KAT ms and the NAD-dependent sirtuin-like deacetylase Rv1151c [27] . We and others have shown that a number of proteins that are acylated by KATlike enzymes are deacylated by Rv1151c [29, 40] . We show here that synthesis of cell wall lipids is also regulated by acylation of FadD22. This raises the interesting possibility that mycobacterial cell wall and lipid composition are modulated by environmental signals that can control the level of bacterial cAMP and/or the activity of the sirtuin. It therefore may be of interest to investigate levels of cAMP in a variety of M. tuberculosis strains, and to correlate this with KAT, FadD22 and Rv1151c expression along with PGL levels.
Among the three FadDs (FadD22, FadD29 and FadD28) that are involved in PGL biosynthesis (Fig. 1) , only FadD22 was acylated in vitro by KAT bcg [29] . Therefore, mycobacteria regulate PGL production at the initial step of biosynthesis by inhibiting the formation of starter units in a cAMP-and acylation-dependent manner. FadD28 is required for PDIM production and acylates long-chain fatty acids required for the generation of mycocerosic acid (Fig. 1) . Thus inhibition of FadD28 activity by acylation would prevent formation of both PDIMs and PGLs. In a detailed analysis using Western blotting with acyl lysine antibodies, followed by mass spectrometric analysis of tryptic peptides [29] , we were unable to detect KAT bcg -mediated acylation of either FadD28 or FadD29. However, since the lysine residue at the active sites in these proteins is present within a sequence of amino acids that serve as a loose consensus for acylation by GNAT-like enzymes [41] , it is possible that FadD28 and FadD29 could serve as substrates for one of the many putative GNAT-like enzymes in mycobacteria [42] .
It is not clear why overexpression of FadD22 in M. smegmatis should result in the production of a polar lipid (Fig. 3c) . There is no ortholog of Rv2949c (chorismate pyruvate lyase) [43] in the M. smegmatis genome, thereby preventing the generation of p-HBA that serves as the substrate for FadD22 (Fig. 1) . It is possible that in the absence of its natural substrate, FadD22 could activate other short-chain fatty acids The production of cAMP (by either one or more adenylyl cyclases in mycobacteria) regulates the activity of KAT bcg by binding to the cyclic nucleotide binding domain [25] . The resulting conformational change [26, 33] in KAT bcg allows the acyltransferase domain to acylate a lysine residue (Lys 479) in FadD22 [29] present in its active site, thereby inhibiting the activity of FadD22. Since FadD22 activity is essential for PGL biosynthesis, levels of PGLs will be reduced in the mycobacterial cell, thereby attenuating its virulence. Solid arrows indicate direct utilization of the molecules indicated, while open arrows indicate allosteric regulation of activity by a binding event. Dashed arrows represent the multiple steps involved in the biosynthesis of PGLs, and mechanisms that modulate the virulence of pathogenic mycobacteria.
that enhance the production of phosphatidylinositol derivatives [44] . The position of the spot, following overexpression of FadD22 in the Dkat ms strain, suggests that it is more apolar than the phosphatidylinositol mannoside, Ac2PIM2 (Figs 3c and S1), and could represent an unusual PIM derivative.
It is interesting to note that PGLs are important virulence factors in M. leprae, and play pleiotropic roles during the course of leprosy [45, 46] . Despite dramatic pseudogenization, a functional orthologue of KAT mt (ML0187) was identified in the M. leprae genome, with more than 70 % identity with KAT mt . Importantly, ML0187 retains the arginine residue important for cAMP binding, as well as the glutamate in the acyltransferase domain [25] . There are predicted to be four functional adenylyl cyclases in M. leprae [47] and one of these has been biochemically characterized [48] . Moreover, a functional orthologue of Rv1151c, can be found in the M. leprae genome with 85 % sequence identity. Thus, the ability to regulate PGL biosynthesis by cAMP in virulent mycobacteria appears to be an evolutionarily conserved pathway. Therefore, targeting these processes in the cell may be an attractive approach to modulate the virulence of these pathogens. 
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